bpc-157 medical uses for athletes and injury treatment: Science, safety, and legal concerns The Hidden Risks of BPC‑157:

Initially investigated for its potential to treat neurodegenerative diseases like Alzheimers and Parkinsons, this small synthetic peptide is known to bind with high affinity to hepatocyte growth factor (HGF) and its receptor c-Met, thereby promoting neuronal differentiation, dendritic branching, and synaptic plasticity

Book your appointment or schedule a free consultation today

Untreated hypogonadism and testosterone replacement therapy in hypogonadal men are associated with a decreased risk of subsequent prostate cancer: a population-based study

Stay 30 mg per day, monitor how you feel, and consult a clinician if pregnant, nursing, or on cancer therapies (excess c-Met activation is theoretically oncogenic).